X-114731430-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_000868.4(HTR2C):c.172C>T(p.Leu58Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,208,306 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000027 ( 0 hom. 2 hem. )
Consequence
HTR2C
NM_000868.4 missense
NM_000868.4 missense
Scores
6
8
Clinical Significance
Conservation
PhyloP100: 0.753
Genes affected
HTR2C (HGNC:5295): (5-hydroxytryptamine receptor 2C) This gene encodes a seven-transmembrane G-protein-coupled receptor. The encoded protein responds to signaling through the neurotransmitter serotonin. The mRNA of this gene is subject to multiple RNA editing events, where adenosine residues encoded by the genome are converted to inosines. RNA editing is predicted to alter the structure of the second intracellular loop, thereby generating alternate protein forms with decreased ability to interact with G proteins. Abnormalities in RNA editing of this gene have been detected in victims of suicide that suffer from depression. In addition, naturally-occuring variation in the promoter and 5' non-coding and coding regions of this gene may show statistically-significant association with mental illness and behavioral disorders. Alternative splicing results in multiple different transcript variants. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.31066293).
BS2
High Hemizygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTR2C | NM_000868.4 | c.172C>T | p.Leu58Phe | missense_variant | 4/6 | ENST00000276198.6 | NP_000859.2 | |
HTR2C | NM_001256760.3 | c.172C>T | p.Leu58Phe | missense_variant | 5/7 | NP_001243689.2 | ||
HTR2C | NM_001256761.3 | c.172C>T | p.Leu58Phe | missense_variant | 4/6 | NP_001243690.2 | ||
LOC105373313 | XR_001755943.2 | n.574-654G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTR2C | ENST00000276198.6 | c.172C>T | p.Leu58Phe | missense_variant | 4/6 | 1 | NM_000868.4 | ENSP00000276198.1 | ||
HTR2C | ENST00000371951.5 | c.172C>T | p.Leu58Phe | missense_variant | 5/7 | 1 | ENSP00000361019.1 | |||
HTR2C | ENST00000371950.3 | c.172C>T | p.Leu58Phe | missense_variant | 4/6 | 1 | ENSP00000361018.3 |
Frequencies
GnomAD3 genomes AF: 0.00000902 AC: 1AN: 110821Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33029
GnomAD3 genomes
AF:
AC:
1
AN:
110821
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33029
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183487Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67919
GnomAD3 exomes
AF:
AC:
1
AN:
183487
Hom.:
AF XY:
AC XY:
1
AN XY:
67919
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1097485Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 2AN XY: 362847
GnomAD4 exome
AF:
AC:
3
AN:
1097485
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
362847
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000902 AC: 1AN: 110821Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33029
GnomAD4 genome
AF:
AC:
1
AN:
110821
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33029
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
HTR2C-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 19, 2024 | The HTR2C c.172C>T variant is predicted to result in the amino acid substitution p.Leu58Phe. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0011% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Vest4
MutPred
Gain of catalytic residue at P56 (P = 0.1525);Gain of catalytic residue at P56 (P = 0.1525);Gain of catalytic residue at P56 (P = 0.1525);
MVP
MPC
1.0
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at